Showing results (361-370 of 379) with videos related to
Sort By:
Pageof 38
Scientific Reports|February 8, 2019
S100A8 & S100A9: Alarmin mediated inflammation in tendinopathyLindsay A N Crowe, Michael McLean, Susan M Kitson, et al.Clinical Genitourinary Cancer|February 9, 2022
Establishing metastatic prostate cancer quality indicators using a modified Delphi approachJia Zheng, Fanny Sampurno, Daniel J George, et al.Neurology|October 10, 2001
Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathyG Schifitto, C Yiannoutsos, D M Simpson, et al.Science (New York, N.Y.)|March 24, 2018
Two-billion-year-old evaporites capture Earth's great oxidationC L Blättler, M W Claire, A R Prave, et al.Journal of the American Medical Informatics Association : JAMIA|January 20, 2022
Knowledge and insights from a maturing international clinical quality registryFanny Sampurno, Christoph Kowalski, Sarah E Connor, et al.The Lancet. Oncology|March 4, 2014
Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trialDavid P Dearnaley, Gordana Jovic, Isabel Syndikus, et al.The Journal of Allergy and Clinical Immunology|October 18, 2016
The role of microRNA-155/liver X receptor pathway in experimental and idiopathic pulmonary fibrosisMariola Kurowska-Stolarska, Manhl K Hasoo, David J Welsh, et al.Cancer|September 23, 2024
Cardiovascular disease and stroke following cancer and cancer treatment in older adultsJaidyn Muhandiramge, John R Zalcberg, Erica T Warner, et al.Neurology|March 17, 2000
A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection. AIDS Clinical Trials Group Team 291J C McArthur, C Yiannoutsos, D M Simpson, et al.European Urology Oncology|July 9, 2026
Quality of Life After Postprostatectomy Radiotherapy: A TROG 08.03 RAVES Randomized Controlled Trial SubstudyJustin Smith, Gill M Duchesne, Andrew Kneebone, et al.Pageof 38